Innate Pharma S.A.

Innate Pharma S.A.verified

IPHA

Price:

$1.63

Market Cap:

$126.60M

Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 ...[Read more]

Industry

Biotechnology

IPO Date

2019-10-17

Stock Exchange

NASDAQ

Ticker

IPHA

The Dividend Yield as of November 2024 (TTM) for Innate Pharma S.A. (IPHA) is 0%

According to Innate Pharma S.A.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Innate Pharma S.A. (IPHA) Historical Dividend Yield (quarterly & annually)

How has IPHA Dividend Yield performed in the past?

The mean historical Dividend Yield of Innate Pharma S.A. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), IPHA's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Innate Pharma S.A. (IPHA) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Innate Pharma S.A. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

Innate Pharma S.A. (IPHA) Average Dividend Yield

How has IPHA Dividend Yield performed in the past?

The current Dividend Yield of Innate Pharma S.A. (IPHA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Innate Pharma S.A. (IPHA) Dividend Yield vs. Peers

How is IPHA’s Dividend Yield compared to its peers?

Innate Pharma S.A.’s Dividend Yield is less than Eliem Therapeutics, Inc. (0%), less than HCW Biologics Inc. (0%), less than Inhibrx Biosciences, Inc. (6.04%), less than Anebulo Pharmaceuticals, Inc. (0%), less than Pardes Biosciences, Inc. (0%), less than Shattuck Labs, Inc. (0%), less than Champions Oncology, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Addex Therapeutics Ltd (0%), less than Aptorum Group Limited (0%), less than Celyad Oncology SA (0%), less than Dyadic International, Inc. (0%), less than Molecular Partners AG (0%), less than MediciNova, Inc. (0%), less than Cyteir Therapeutics, Inc. (0%),

Build a custom stock screener for Innate Pharma S.A. (IPHA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innate Pharma S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Innate Pharma S.A. (IPHA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Innate Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Innate Pharma S.A.'s Dividend Yield?

How is the Dividend Yield calculated for Innate Pharma S.A. (IPHA)?

What is the highest Dividend Yield for Innate Pharma S.A. (IPHA)?

What is the 3-year average Dividend Yield for Innate Pharma S.A. (IPHA)?

What is the 5-year average Dividend Yield for Innate Pharma S.A. (IPHA)?

How does the current Dividend Yield for Innate Pharma S.A. (IPHA) compare to its historical average?